ArticleScientific reports2020

Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer.

Sara Moufarrij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.